Pharmacokinetic Interactions of Maraviroc with Darunavir-Ritonavir, Etravirine, and Etravirine-Darunavir-Ritonavir in Healthy Volunteers: Results of Two Drug Interaction Trials

The effects of darunavir-ritonavir at 600 and 100 mg twice daily (b.i.d.) alone, 200 mg of etravirine b.i.d. alone, or 600 and 100 mg of darunavir-ritonavir b.i.d. with 200 mg etravirine b.i.d. at steady state on the steady-state pharmacokinetics of maraviroc, and vice versa, in healthy volunteers w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Kakuda, Thomas N., Abel, Samantha, Davis, John, Hamlin, Julia, Schöller-Gyüre, Monika, Mack, Rebecca, Ndongo, Noella, Petit, Wendy, Ridgway, Caroline, Sekar, Vanitha, Tweedy, Sarah, Hoetelmans, Richard M. W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3088221/
https://ncbi.nlm.nih.gov/pubmed/21383098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01046-10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados